Solifenacin is more effective than tolterodine extended-release (ER) in the treatment of overactive bladder

Source: Inpharma, Volume 1, Number 1482, 2005-04-09 , pp. 19-19(1)

Publisher: Adis International

Keywords: Astellas-Pharma; Overactive-bladder, treatment; Solifenacin, therapeutic use; Tolterodine, therapeutic use; Trial-result-clinical

Document Type: Short communication

Publication date: 2005-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers